| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,028,000 | 2,864,000 | 5,978,000 | 2,760,000 | | Cost of Revenue | 566,000 | 918,000 | 2,092,000 | 331,000 | | | Gross Profit | 1,462,000 | 1,946,000 | 3,886,000 | 2,429,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 402,000 | 179,000 | (751,000) | 1,077,000 | | Non Recurring | 6,511,000 |
-
|
-
|
-
| | Others | 693,000 | 1,217,000 | 870,000 | 846,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,144,000) | 550,000 | 3,767,000 | 506,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (10,403,000) | 37,000 | 845,000 | | Earnings Before Interest And Taxes | (6,144,000) | (9,853,000) | 3,804,000 | 1,351,000 | | Interest Expense | 83,000 | 68,000 | 69,000 | 90,000 | | Income Before Tax | (6,227,000) | (9,921,000) | 3,735,000 | 1,261,000 | | Income Tax Expense | (2,269,000) | (3,088,000) | 1,226,000 | 667,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,958,000) | (6,833,000) | 2,509,000 | 594,000 | | | Non-recurring Events | | Discontinued Operations | (1,000) | 17,000 | 109,000 | 707,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,959,000) | (6,816,000) | 2,618,000 | 1,301,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| (3,000) | | | Net Income Applicable To Common Shares | ($3,959,000) | ($6,816,000) | $2,618,000 | $1,298,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
